Find drug development pipeline and deal Updates information

Lead Product(s): Squalene

Therapeutic Area: Infections and Infectious Diseases

Highest Development Status: Preclinical Product Type: Small molecule

Partner/Sponsor/Collaborator: University of Queensland

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Collaboration February 12, 2020

Details:

CSL said it will provide technical expertise and a donation of MF59 to the University of Queensland’s preclinical development program.